Cronos Group Inc. (CRON) Financials

CRON Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 1.2 billion 62.4 million
March 31, 2026 1.2 billion 48.5 million
Dec. 31, 2025 1.2 billion 54.2 million
Sept. 30, 2025 1.2 billion 46.4 million

CRON Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 17.1 million 1.6 million
March 31, 2026 8.9 million 1.3 million
Dec. 31, 2025 9.9 million -5.8 million
Sept. 30, 2025 8.7 million 2.3 million

CRON Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 37.8 million
March 31, 2026 13.6 million
Dec. 31, 2025 2.4 million
Sept. 30, 2025 28.3 million

CRON Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 797.0 million - 1.3 million
March 31, 2026 824.6 million - 1.1 million
Dec. 31, 2025 831.8 million - 1.5 million
Sept. 30, 2025 824.2 million - 1.7 million

CRON Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 385.3 million
March 31, 2026 385.3 million
Dec. 31, 2025 385.3 million
Sept. 30, 2025 385.3 million

CRON Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.8 million 1.2 million 17.6 million 6.8 million
March 31, 2026 1.8 million 1.4 million 17.4 million 5.6 million
Dec. 31, 2025 2.2 million 1.4 million 13.6 million 6.6 million
Sept. 30, 2025 4.6 million 1.3 million 16.9 million 5.3 million

CRON Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 70.6 million 42.1 million
March 31, 2026 44.6 million 26.1 million
Dec. 31, 2025 91.3 million 75.1 million
Sept. 30, 2025 36.3 million 18.0 million

CRON Revenue by Segment

Graph available only for paid members. Upgrade to see it.

CRON

Price: $3.22

52 week price:
2.28
3.61

Payout Ratio Range:
-0.75%
-0.49%

Earnings Per Share: 0.20 USD

P/E Ratio: 15.85

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Canada

Volume: 1.5 million

Market Capitalization: 1.2 billion

Links: